301206 三元生物
2024/09 - 九个月2023/122022/122021/122020/12

盈利能力分析
净资产收益率 ROE (%)1.7871.2865.77868.85354.210
总资产报酬率 ROA (%)1.6921.2165.03344.33135.640
投入资产回报率 ROIC (%)1.7161.2375.20947.60631.850

边际利润分析
销售毛利率 (%)10.2963.05014.05541.99142.269
营业利润率 (%)16.60312.28827.56736.99434.874
息税前利润/营业总收入 (%)15.38210.78418.89637.28235.728
净利润/营业总收入 (%)15.73211.78724.25331.95929.696

收益指标分析
经营活动净收益/利润总额(%)2.376-83.26249.97898.712100.011
价值变动净收益/利润总额(%)95.683181.08446.8290.0410.163
营业外收支净额/利润总额(%)0.2910.539-1.1400.020-1.103

偿债能力分析
流动比率 (X)17.9011.4353.2261.4261.463
速动比率 (X)17.2680.9702.7591.2281.199
资产负债率 (%)5.0285.6635.11636.03334.743
带息债务/全部投入资本 (%)2.4043.4302.21229.487--
股东权益/带息债务 (%)4,013.8482,785.4644,380.713233.765242.424
股东权益/负债合计 (%)1,888.8581,665.9171,854.666177.527187.829
利息保障倍数 (X)-12.112-6.867-2.260132.86228.945

营运能力分析
应收账款周转天数 (天)40.01546.74651.30522.8080.000
存货周转天数 (天)65.21074.75064.83633.4060.000